{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:15:27Z","timestamp":1783570527665,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["KAKENHI, Grant Number JP23K06243 (Japan)"],"award-info":[{"award-number":["KAKENHI, Grant Number JP23K06243 (Japan)"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharm Health Care Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Even after alcohol detoxification, 50\u201380% of patients with alcohol use disorder (AUD) exhibit cognitive impairments, which affect key domains of social functioning, such as employment, interpersonal relationships, and communication. Therefore, it is necessary to assess cognitive function in patients with AUD in routine practice. However, existing cognitive function assessments are difficult to apply in routine practice because they require a long time, are burdensome on patients, and are limited to evaluators with special training. The present study investigated the relationship between a simple and novel assessment, called Psychomotor Function Tests (PFT), and existing Neuropsychological Tests (NT) in patients with AUD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty patients with AUD underwent a cognitive assessment using NT (Raven\u2019s Colored Progressive Matrices, Frontal Assessment Battery (FAB), and Clinical Assessment for Attention (CAT)) as well as tablet-based PFT, with each assessment being conducted twice: 1 week and 2 months after alcohol detoxification with benzodiazepines. Twenty healthy controls underwent the same assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Psychomotor function assessed by PFT was significantly worse in patients with AUD than in healthy controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). At both assessment time points, PFT composite score correlated with the total FAB score (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.500, 0.458) and CAT time required (\n                      <jats:italic>r<\/jats:italic>\n                      = -0.447, -0.496). The CRT, CTT-TT, CTT-PAT and RVIP demonstrated a degree of test-retest reliability (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.816, 0.812, 0.797, 0.676).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The correlations observed between PFT and conventional NT suggest the utility of PFT for evaluating cognitive function in patients with AUD in clinical settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40780-026-00584-0","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:26:11Z","timestamp":1778894771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validity and reliability of a cognitive function assessment tool using psychomotor function tests in patients with alcohol use disorders \u2013 a pilot study \u2013"],"prefix":"10.1186","volume":"12","author":[{"given":"Yuma","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Miyaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manako","family":"Hanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"issue":"5 Suppl 3","key":"584_CR1","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.2146\/ajhp060647","volume":"64","author":"T Cargiulo","year":"2007","unstructured":"Cargiulo T. Understanding the health impact of alcohol dependence. Am J Health Syst Pharm. 2007;64(5 Suppl 3):S5\u201311. https:\/\/doi.org\/10.2146\/ajhp060647.","journal-title":"Am J Health Syst Pharm"},{"key":"584_CR2","unstructured":"World HO. 2018, Global status report on alcohol and health 2018."},{"issue":"8","key":"584_CR3","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","volume":"3","author":"GF Koob","year":"2016","unstructured":"Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760\u201373. https:\/\/doi.org\/10.1016\/S2215-0366(16)00104-8.","journal-title":"Lancet Psychiatry"},{"key":"584_CR4","doi-asserted-by":"publisher","first-page":"108132","DOI":"10.1016\/j.addbeh.2024.108132","volume":"158","author":"MA Gautron","year":"2024","unstructured":"Gautron MA, Clergue-Duval V, Chantre J, Lejoyeux M, Geoffroy PA. Predictive factors of cognitive impairment in alcohol use disorder inpatients. Addict Behav. 2024;158:108132. https:\/\/doi.org\/10.1016\/j.addbeh.2024.108132.","journal-title":"Addict Behav"},{"issue":"6","key":"584_CR5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1136\/jnnp.68.6.731","volume":"68","author":"H Ihara","year":"2000","unstructured":"Ihara H, Berrios GE, London M. Group and case study of the dysexecutive syndrome in alcoholism without amnesia. J Neurol Neurosurg Psychiatry. 2000;68(6):731\u20137. https:\/\/doi.org\/10.1136\/jnnp.68.6.731.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"584_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/B978-0-444-62619-6.00012-4","volume":"125","author":"M Oscar-Berman","year":"2014","unstructured":"Oscar-Berman M, Valmas MM, Sawyer KS, Ruiz SM, Luhar RB, Gravitz ZR. Profiles of impaired, spared, and recovered neuropsychologic processes in alcoholism. Handb Clin Neurol. 2014;125:183\u2013210. https:\/\/doi.org\/10.1016\/B978-0-444-62619-6.00012-4.","journal-title":"Handb Clin Neurol"},{"key":"584_CR7","doi-asserted-by":"publisher","first-page":"106350","DOI":"10.1016\/j.addbeh.2020.106350","volume":"105","author":"A Maillard","year":"2020","unstructured":"Maillard A, Poussier H, Boudehent C, Lannuzel C, Vicente A, Vabret F, Cabe N, Pitel AL. Short-term neuropsychological recovery in alcohol use disorder: A retrospective clinical study. Addict Behav. 2020;105:106350. https:\/\/doi.org\/10.1016\/j.addbeh.2020.106350.","journal-title":"Addict Behav"},{"key":"584_CR8","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. Fifth edition, text revision. American Psychiatric Association Publishing; 2022.","DOI":"10.1176\/appi.books.9780890425787"},{"issue":"8","key":"584_CR9","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/acer.13431","volume":"41","author":"AP Le Berre","year":"2017","unstructured":"Le Berre AP, Fama R, Sullivan EV. Executive Functions, Memory, and Social Cognitive Deficits and Recovery in Chronic Alcoholism: A Critical Review to Inform Future Research. Alcohol Clin Exp Res. 2017;41(8):1432\u201343. https:\/\/doi.org\/10.1111\/acer.13431.","journal-title":"Alcohol Clin Exp Res"},{"key":"584_CR10","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.neubiorev.2016.09.030","volume":"71","author":"S Dom\u00ednguez-Salas","year":"2016","unstructured":"Dom\u00ednguez-Salas S, D\u00edaz-Batanero C, Lozano-Rojas OM, Verdejo-Garc\u00eda A. Impact of general cognition and executive function deficits on addiction treatment outcomes: Systematic review and discussion of neurocognitive pathways. Neurosci Biobehav Rev. 2016;71:772\u2013801. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.09.030.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"584_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pbb.2009.04.018","volume":"93","author":"FT Crews","year":"2009","unstructured":"Crews FT, Boettiger CA. Impulsivity, frontal lobes and risk for addiction. Pharmacol Biochem Behav. 2009;93(3):237\u201347. https:\/\/doi.org\/10.1016\/j.pbb.2009.04.018.","journal-title":"Pharmacol Biochem Behav"},{"issue":"7","key":"584_CR12","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1017\/S135561772100103X","volume":"28","author":"KY Ko","year":"2022","unstructured":"Ko KY, Ridley N, Bryce SD, Allott K, Smith A, Kamminga J. Screening Tools for Cognitive Impairment in Adults with Substance Use Disorders: A Systematic Review. J Int Neuropsychol Soc. 2022;28(7):756\u201379. https:\/\/doi.org\/10.1017\/S135561772100103X.","journal-title":"J Int Neuropsychol Soc"},{"issue":"4","key":"584_CR13","doi-asserted-by":"publisher","first-page":"e06719","DOI":"10.1016\/j.heliyon.2021.e06719","volume":"7","author":"H Kamei","year":"2021","unstructured":"Kamei H, Takeuchi I, Yamada Y, Hanya M, Fujita K. Usefulness of a psychomotor function test as a cognitive function scale for patients with schizophrenia: A pilot study. Heliyon. 2021;7(4):e06719. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06719.","journal-title":"Heliyon"},{"key":"584_CR14","doi-asserted-by":"publisher","first-page":"100390","DOI":"10.1016\/j.scog.2025.100390","volume":"42","author":"Y Shimizu","year":"2025","unstructured":"Shimizu Y, Takeuchi I, Hatano M, Hanya M, Fujita K, Iwata N, Kamei H. Development of a cognitive function assessment tool based on psychomotor function tests in patients with schizophrenia. Schizophr Res Cogn. 2025;42:100390. https:\/\/doi.org\/10.1016\/j.scog.2025.100390.","journal-title":"Schizophr Res Cogn"},{"issue":"6","key":"584_CR15","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB Saunders","year":"1993","unstructured":"Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption\u2013II. Addiction. 1993;88(6):791\u2013804. https:\/\/doi.org\/10.1111\/j.1360-0443.1993.tb02093.x.","journal-title":"Addiction"},{"issue":"3","key":"584_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6.","journal-title":"J Psychiatr Res"},{"issue":"3","key":"584_CR17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/jgs.17010","volume":"69","author":"R Sakurai","year":"2021","unstructured":"Sakurai R, Kim Y, Inagaki H, Tokumaru AM, Sakurai K, Shimoji K, Kitamura A, Watanabe Y, Shinkai S, Awata S. MMSE Cutoff Discriminates Hippocampal Atrophy: Neural Evidence for the Cutoff of 24 Points. J Am Geriatr Soc. 2021;69(3):839\u201341. https:\/\/doi.org\/10.1111\/jgs.17010.","journal-title":"J Am Geriatr Soc"},{"key":"584_CR18","unstructured":"Sugishita M, Yamazaki K. Raven\u2019s Colored Progressive Materices. Nihon Bunka Kagakusha; 1993. (in Japanese)."},{"key":"584_CR19","volume-title":"Coloured progressive matrices, Sets A, Ab","author":"JC Raven","year":"1962","unstructured":"Raven JC. Coloured progressive matrices, Sets A, Ab. Lewis: B; 1962."},{"issue":"11","key":"584_CR20","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1212\/wnl.55.11.1621","volume":"55","author":"B Dubois","year":"2000","unstructured":"Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55(11):1621\u20136. https:\/\/doi.org\/10.1212\/wnl.55.11.1621.","journal-title":"Neurology"},{"issue":"1","key":"584_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.psychres.2006.04.004","volume":"153","author":"A Kugo","year":"2007","unstructured":"Kugo A, Terada S, Ata T, Ido Y, Kado Y, Ishihara T, Hikiji M, Fujisawa Y, Sasaki K, Kuroda S. Japanese version of the Frontal Assessment Battery for dementia. Psychiatry Res. 2007;153(1):69\u201375. https:\/\/doi.org\/10.1016\/j.psychres.2006.04.004.","journal-title":"Psychiatry Res"},{"issue":"3","key":"584_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2496\/hbfr.26.310","volume":"26","author":"M Kato","year":"2006","unstructured":"Kato M. The development and standardization of Clinical Assessment for Attention (CAT) and Clinical Assessment for Spontaneity (CAS). High brain function Res. 2006;26(3):310\u20139. (in Japanese).","journal-title":"High brain function Res"},{"issue":"7","key":"584_CR23","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28\u201337.","journal-title":"Psychiatry (Edgmont)"},{"key":"584_CR24","unstructured":"Japan Society for Higher Brain Dysfunction & Brain Function Test Committee. Clinical Assessment for Attention-Revised (CAT-R), Clinical Assessment for Spontaneity (CAS). Shinkoh Igaku; 2022. (in Japanese)."},{"issue":"5","key":"584_CR25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.30773\/pi.2017.09.27.1","volume":"15","author":"L Ioime","year":"2018","unstructured":"Ioime L, Guglielmo R, Affini GF, Quatrale M, Martinotti G, Callea A, Savi E, Janiri L. Neuropsychological Performance in Alcohol Dependent Patients: A One-Year Longitudinal Study. Psychiatry Investig. 2018;15(5):505\u201313. https:\/\/doi.org\/10.30773\/pi.2017.09.27.1.","journal-title":"Psychiatry Investig"},{"issue":"8","key":"584_CR26","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/hup.538","volume":"18","author":"H Kamei","year":"2003","unstructured":"Kamei H, Noda Y, Ishikawa K, Senzaki K, Muraoka I, Hasegawa Y, Hindmarch I, Nabeshima T. Comparative study of acute effects of single doses of fexofenadine, olopatadine, d-chlorpheniramine and placebo on psychomotor function in healthy volunteers. Hum Psychopharmacol. 2003;18(8):611\u20138. https:\/\/doi.org\/10.1002\/hup.538.","journal-title":"Hum Psychopharmacol"},{"issue":"4","key":"584_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00403-011-1192-2","volume":"304","author":"H Kamei","year":"2012","unstructured":"Kamei H, Isaji A, Noda Y, Ishikawa K, Senzaki K, Yamada K, Sugiura K, Tomita Y, Nabeshima T. Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers. Arch Dermatol Res. 2012;304(4):263\u201372. https:\/\/doi.org\/10.1007\/s00403-011-1192-2.","journal-title":"Arch Dermatol Res"},{"issue":"10","key":"584_CR28","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1097\/01.ALC.0000090142.11260.D7","volume":"27","author":"T Duka","year":"2003","unstructured":"Duka T, Townshend JM, Collier K, Stephens DN. Impairment in cognitive functions after multiple detoxifications in alcoholic inpatients. Alcohol Clin Exp Res. 2003;27(10):1563\u201372. https:\/\/doi.org\/10.1097\/01.ALC.0000090142.11260.D7.","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"584_CR29","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/alcalc\/agp030","volume":"44","author":"S Loeber","year":"2009","unstructured":"Loeber S, Duka T, Welzel H, Nakovics H, Heinz A, Flor H, Mann K. Impairment of cognitive abilities and decision making after chronic use of alcohol: the impact of multiple detoxifications. Alcohol Alcohol. 2009;44(4):372\u201381. https:\/\/doi.org\/10.1093\/alcalc\/agp030.","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"584_CR30","first-page":"117","volume":"26","author":"K Mizushima","year":"2024","unstructured":"Mizushima K, Morishita N, Ishimoto F, Kobayashi H, Kato M, Uchida A, Yoshida S, Okuda M, Mizutani H. Dissociation between objective and self-assessed neuropsychological assessments of alcoholics\u2019 engagement in attention programs. J Japanese Soc Alcohol-Related Probl. 2024;26(1):117\u201323. (in Japanese).","journal-title":"J Japanese Soc Alcohol-Related Probl"},{"issue":"4","key":"584_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.12945\/j.aorta.2016.16.014","volume":"4","author":"AE Curtis","year":"2016","unstructured":"Curtis AE, Smith TA, Ziganshin BA, Elefteriades JA. The Mystery of the Z-Score. Aorta (Stamford). 2016;4(4):124\u201330. https:\/\/doi.org\/10.12945\/j.aorta.2016.16.014.","journal-title":"Aorta (Stamford)"},{"issue":"3","key":"584_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","volume":"18","author":"H Akoglu","year":"2018","unstructured":"Akoglu H. User\u2019s guide to correlation coefficients. Turk J Emerg Med. 2018;18(3):91\u20133. https:\/\/doi.org\/10.1016\/j.tjem.2018.08.001.","journal-title":"Turk J Emerg Med"},{"key":"584_CR33","doi-asserted-by":"publisher","unstructured":"Beato Rog\u00e9rio et al. 2012. Frontal assessment battery in a Brazilian sample of healthy controls: normative data. Arquivos de Neuro-psiquiatria, 70: 278\u201380. https:\/\/doi.org\/10.1590\/S0004-282X2012005000009","DOI":"10.1590\/S0004-282X2012005000009"},{"issue":"4","key":"584_CR34","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/acer.12308","volume":"38","author":"EM Nakamura-Palacios","year":"2014","unstructured":"Nakamura-Palacios EM, Souza RS, Zago-Gomes MP, de Melo AM, Braga FS, Kubo TT, Gasparetto EL. Gray matter volume in left rostral middle frontal and left cerebellar cortices predicts frontal executive performance in alcoholic subjects. Alcohol Clin Exp Res. 2014;38(4):1126\u201333. https:\/\/doi.org\/10.1111\/acer.12308.","journal-title":"Alcohol Clin Exp Res"},{"issue":"10","key":"584_CR35","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.addbeh.2010.05.005","volume":"35","author":"PJ Cunha","year":"2010","unstructured":"Cunha PJ, Nicastri S, de Andrade AG, Bolla KI. The frontal assessment battery (FAB) reveals neurocognitive dysfunction in substance-dependent individuals in distinct executive domains: Abstract reasoning, motor programming, and cognitive flexibility. Addict Behav. 2010;35(10):875\u201381. https:\/\/doi.org\/10.1016\/j.addbeh.2010.05.005.","journal-title":"Addict Behav"},{"issue":"4","key":"584_CR36","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/npr2.12395","volume":"43","author":"K Kurihara","year":"2023","unstructured":"Kurihara K, Shiroma A, Koda M, Shinzato H, Takaesu Y, Kondo T. Age-related cognitive decline is accelerated in alcohol use disorder. Neuropsychopharmacol Rep. 2023;43(4):587\u201395. https:\/\/doi.org\/10.1002\/npr2.12395.","journal-title":"Neuropsychopharmacol Rep"},{"issue":"11","key":"584_CR37","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1111\/j.1530-0277.2007.00484.x","volume":"31","author":"B De Wilde","year":"2007","unstructured":"De Wilde B, Dom G, Hulstijn W, Sabbe B. Motor functioning and alcohol dependence. Alcohol Clin Exp Res. 2007;31(11):1820\u20135. https:\/\/doi.org\/10.1111\/j.1530-0277.2007.00484.x.","journal-title":"Alcohol Clin Exp Res"},{"key":"584_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.5958\/2320-608X.2018.00131.2","volume":"64","author":"C Kumar","year":"2018","unstructured":"Kumar C, Kiran, et al. Impact of chronic alcoholism on temporal cognition and coordination of motor activity. Int J Physiol. 2018;64:124\u20137. https:\/\/doi.org\/10.5958\/2320-608X.2018.00131.2.","journal-title":"Int J Physiol"},{"issue":"11","key":"584_CR39","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1111\/acer.12888","volume":"39","author":"L Ritz","year":"2015","unstructured":"Ritz L, Lannuzel C, Boudehent C, Vabret F, Bordas N, Segobin S, Eustache F, Pitel AL, Beaunieux H. Validation of a brief screening tool for alcohol-related neuropsychological impairments. Alcohol Clin Exp Res. 2015;39(11):2249\u201360. https:\/\/doi.org\/10.1111\/acer.12888.","journal-title":"Alcohol Clin Exp Res"}],"container-title":["Journal of Pharmaceutical Health Care and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40780-026-00584-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-026-00584-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-026-00584-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:43:04Z","timestamp":1783568584000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40780-026-00584-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1186\/s40780-026-00584-0","relation":{},"ISSN":["2055-0294"],"issn-type":[{"value":"2055-0294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was conducted after receiving approval and permission from the Ethics Review Committee of Meijo University (Approval No: 2021-23; Date: 12\/21\/2022) and Yagoto Hospital (Approval No: 4; Date: 1\/10\/2023). To be included in this study, the Ethics Review Committee approved participants giving written consent after being informed about the study. Written informed consent was obtained from all participants before any study procedure. Participation was voluntary and they were informed that all the data used was only for scientific purposes. All participants were reassured that they could withdraw from the research at any time. The survey items were presented to the participants along with the study\u2019s purpose, specific methods, and disclosure of research. In addition, they were advised that participation was completely voluntary, their privacy would be strictly protected, and no disadvantages would occur in their medical treatment or daily life. All participants were also given the opportunity to have any questions about the study answered by the researchers. The Ethics Review Committee approved this procedure. The present study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}